India prostate cancer market is forecast to grow at a CAGR of around 9% during the forecast period. The incidence of prostate cancer is less as compared to the western economies as prostate cancer is among the top 3 cancer in men in western economies whereas it is at 16th rank in the incidence cancer cases in the country in 2018. As per the World Health Organization, the estimated new cases in 2018 were 26,000- and 5-year prevalence is around 47,500. In India, the registered cases of prostate cancer are more in big cities such as Bangalore, Mumbai, Pune, Kolkata, Delhi, and Thiruvananthapuram. The data for prostate cancer incidences in India is only indicative as there are no PSA testing norms in India at a mass scale which may result in many prostate cancer cases going unreported. In India, data regarding the true incidence of prostate cancer is limited mainly due to the fact that this entity is not a notifiable disease and there are only a handful of population-based cancer registries in India.